Date Name Title Filing Type Shares Traded Price Total Held
May 12, 2020
Director, President & CEO
Director, President & CEO Form 4 Open market or private sale of non-derivative or derivative security 19,984 $572.47 493,465
May 20, 2020
Director, Chairman of the Board
Director, Chairman of the Board Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 77,309 $30.63 497,063
Mar 11, 2020
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Other acquisition or disposition -- -- 500,000
Feb 25, 2020
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Other acquisition or disposition -- -- 500,000
Jun 13, 2019
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 500,000 -- 500,000
Feb 10, 2017
Director, President & CSO
Director, President & CSO Form 5 Other acquisition or disposition -- -- 500,000
Dec 16, 2016
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 89,427 -- 500,000
Jul 21, 2016
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Bona fide gift 500,000 -- 500,000
Dec 17, 2015
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 1,921 -- 500,000
Dec 02, 2015
Director, President Regeneron Laboratori
Director, President Regeneron Laboratori Form 4 Open market or private sale of non-derivative or derivative security 1,900 $555.26 500,000

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.